Several studies in the last few years have demonstrated the potential application of targeting the cGMP/PKG pathway in the treatment of colon cancer [7, 30, 31] and breast cancers [8, 9, 11] but very little is known about this signaling pathway in melanoma. The gene discussed is PRKG1; the disease is breast carcinoma.